Brief: Medicus Pharma - Uae Department Of Health Grants Ind Authorization For Precision-E2 Phase 2A Study Of Teverelix
31/07/2026 12:30
BRIEF-Medicus Pharma - Uae Department Of Health Grants Ind Authorization For Precision-E2 Phase 2A Study Of Teverelix July 31 (Reuters) - Medicus Pharma Ltd MDCX.O:
MEDICUS PHARMA - UAE DEPARTMENT OF HEALTH GRANTS IND AUTHORIZATION FOR PRECISION-E2 PHASE 2A STUDY OF TEVERELIX
Source text: ID:nGNX7vvYL3
Further company coverage: MDCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicus Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Medicus Pharma Submits Optimized Teverelix® Registrational Protocol To FDA To Create Partner Ready Program In Advanced Prostate Cancer